Investview Q2 FY26 operating loss widens to $2.1 million; revenue drops 73% to $2.47 million
INVU•Product sales and costs
- Health and wellness product sales slid 82% to USD 242,552; coffee sales contributed USD 132,045 following a January 2026 launch.
- Operating costs and expenses dropped 48% to USD 4.53 million on lower commissions, cost of sales and service, and salary and related costs.
Quarterly results deteriorate
- Investview posted a Q2 operating loss of USD 2.1 million, swinging from operating income of USD 0.4 million a year earlier.
- Revenue fell 73% to USD 2.47 million, driven by a 73% drop in membership revenue to USD 2.1 million.
Management explains DTC contraction
- Management tied the direct-to-consumer contraction to a December 2025 UOKiK administrative decision in Poland.
- The company said it is appealing the decision while continuing operations there.
